BTAA Board Announcement – May 2026
Brain Tumour Alliance Australia is pleased to announce the appointment of its new Board, bringing together leaders in governance, advocacy, research engagement and lived experience to strengthen national advocacy for all Australians affected by brain tumours.
At the recent extraordinary AGM, all existing committee members were formally appointed to the Board, ensuring continuity and a strong foundation for BTAA’s expanding national role.
As Australia’s peak consumer organisation for the brain tumour community, BTAA advocates for equitable access to world‑class research, clinical trials, multidisciplinary care and high‑quality support services. The new Board will guide this work at a national level and amplify the voice of people living with brain tumours and their families.
BTAA Board 2026
Craig Cardinal (Chair)
Philip Dunn (Vice Chair)
Pat Wynn (Treasurer)
Billy Williams (Public Officer)
Diane Dunn (Secretary)
Pam Hubner
Craig Steele
Gerry Tye
Sally Cane
Damian Ogden
Professor Darrell Evans
Brett Levin
Dianne Legge
Professor Divya Mehta
Emma Pitfield
Dr Gian Sberna
Jaimee Eaton
Mainul Haque OAM
Oliver Jarrett
Biographies for all Directors will be available on our new website, launching early June 2026.
Contact enquiries@btaa.org.au for more information about the BTAA Board.

Pictured (left to right): Amanda Redford (Executive Officer), Gerry Tye, Damian Ogden, Craig Cardinal (Chair), Oliver Jarrett, Mainul Haque, Billy Williams (Public Officer), Sally Cane, Darrell Evans, Jaimee Eaton, Craig Steele, Philip Dunn (Vice Chair), Emma Pitfield, Pat Wynn (Treasurer), Pam Hubner, Divya Mehta, Dianne Legge, Diane Dunn (Secretary).
Absent: Brett Levin, Gian Sberna.

